Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Dividend declared
Quarterly results
Credit agrmnt [a]
Director departure
Appointed director
CC transcript
Asset disposition
Inv. presentation

ALLERGAN INC (AGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
02/06/2015 8-K/A Results of Operations and Financial Condition, Other Events
05/09/2014 8-K/A Submission of Matters to a Vote of Security Holders
12/10/2007 8-K/A Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Audited consolidated balance sheets of Esprit Pharma Holding Company, Inc. and Subsidiaries as of December 31, 2006 and 2005 and the related consolidated statement of operations, stockholders' deficit, and cash flows for the year ended December 31, 2006 and for the period from May 6, 2005 (inception) to December 31, 2005",
"Unaudited consolidated balance sheets of Esprit Pharma Holding Company, Inc. and Subsidiaries as of September 30, 2007 and December 31, 2006 and the related consolidated statements of operations, stockholders' deficit, and cash flows for the nine months ended September 30, 2007 and September 30, 2006",
"Unaudited pro forma combined condensed financial statements"
09/24/2007 8-K/A Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "Agreement and Plan of Merger, by and among Allergan, Inc., Esmeralde Acquisition, Inc., Esprit Pharma Holding Company, Inc. and the Escrow Participants' Representative"
09/25/2006 8-K/A Financial Statements and Exhibits
Docs: "Unaudited pro forma combined condensed statement of earnings"
07/21/2006 8-K/A Financial Statements and Exhibits
Docs: "Unaudited pro forma combined condensed statement of earnings"
06/06/2006 8-K/A Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits
Docs: "Consent of Independent Registered Public Accounting Firm",
"Audited consolidated financial statements of Inamed Corporation as of December 31, 2005 and December 31, 2004 and the related consolidated statements of operations, stockholders' equity and comprehensive income (loss), and cash flows for each of the years in the three-year period ended December 31, 2005 and related financial statement schedule",
"Unaudited pro forma combined condensed financial statements"
04/21/2005 8-K/A Cost Associated with Exit or Disposal Activities
09/29/2004 8-K/A Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
12/04/2003 8-K/A Acquisition or disposition of assets, Financial statements and exhibits
07/18/2003 8-K/A Financial statements and exhibits
Docs: "RISK FACTORS AND UNCERTAINTIES"
08/29/2002 8-K/A Acquisition or disposition of assets, Financial statements and exhibits

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy